148 related articles for article (PubMed ID: 28721446)
21. A prostaglandin E1 analog, OP-1206, alleviates 5-fluorouracil-induced injury of rat small intestine.
Hirata K; Horie T
Res Commun Mol Pathol Pharmacol; 1999; 104(3):243-51. PubMed ID: 10741375
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats.
Maeda T; Miyazono Y; Ito K; Hamada K; Sekine S; Horie T
Cancer Chemother Pharmacol; 2010 May; 65(6):1117-23. PubMed ID: 19756603
[TBL] [Abstract][Full Text] [Related]
23. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions.
Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ
Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157
[TBL] [Abstract][Full Text] [Related]
24. [Improvement of intestinal absorption of poorly absorbable drugs by polyamidoamine (PAMAM) dendrimers as novel absorption enhancers].
Yamamoto A
Yakugaku Zasshi; 2010 Sep; 130(9):1123-7. PubMed ID: 20823669
[TBL] [Abstract][Full Text] [Related]
25. Improvement of the Solubility and Intestinal Absorption of Curcumin by N-Acyl Taurates and Elucidation of the Absorption-Enhancing Mechanisms.
Li X; Kawamura A; Sato Y; Morishita M; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Biol Pharm Bull; 2017; 40(12):2175-2182. PubMed ID: 29199240
[TBL] [Abstract][Full Text] [Related]
26. Improvement of intestinal absorption of curcumin by cyclodextrins and the mechanisms underlying absorption enhancement.
Li X; Uehara S; Sawangrat K; Morishita M; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2018 Jan; 535(1-2):340-349. PubMed ID: 29157961
[TBL] [Abstract][Full Text] [Related]
27. Changes in intestinal absorption of 5-fluorouracil-treated rats.
Hirata K; Horie T
Pharmacol Toxicol; 1999 Jul; 85(1):33-6. PubMed ID: 10426161
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic evaluation of the interaction between oral kaempferol and ethanol in rats.
Zhou Z; Wang M; Guo Z; Zhang X
Acta Pharm; 2016 Dec; 66(4):563-568. PubMed ID: 27749255
[TBL] [Abstract][Full Text] [Related]
29. Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs.
Yamamoto A; Tatsumi H; Maruyama M; Uchiyama T; Okada N; Fujita T
J Pharmacol Exp Ther; 2001 Jan; 296(1):84-90. PubMed ID: 11123366
[TBL] [Abstract][Full Text] [Related]
30. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of intestinal absorption of macromolecules by spermine in rats.
Sugita Y; Takao K; Toyama Y; Shirahata A
Amino Acids; 2007 Aug; 33(2):253-60. PubMed ID: 17653818
[TBL] [Abstract][Full Text] [Related]
32. Intestinal transport of 3,6'-disinapoylsucrose, a major active component of Polygala tenuifolia, using Caco-2 cell monolayer and in situ rat intestinal perfusion models.
Chen Y; Liu X; Pan R; Zhu X; Steinmetz A; Liao Y; Wang N; Peng B; Chang Q
Planta Med; 2013 Oct; 79(15):1434-9. PubMed ID: 24043590
[TBL] [Abstract][Full Text] [Related]
33. The effect of wellsolve, a novel solubilizing agent, on the intestinal barrier function and intestinal absorption of griseofulvin in rats.
Hamid KA; Lin Y; Gao Y; Katsumi H; Sakane T; Yamamoto A
Biol Pharm Bull; 2009 Nov; 32(11):1898-905. PubMed ID: 19881305
[TBL] [Abstract][Full Text] [Related]
34. Effect of poly-L-arginine on intestinal absorption of hydrophilic macromolecules in rats.
Yamaki T; Uchida M; Kuwahara Y; Shimazaki Y; Ohtake K; Kimura M; Uchida H; Kobayashi J; Ogihara M; Morimoto Y; Natsume H
Biol Pharm Bull; 2013; 36(3):496-500. PubMed ID: 23257956
[TBL] [Abstract][Full Text] [Related]
35. Effects of pharmaceutical excipients on membrane permeability in rat small intestine.
Takizawa Y; Kishimoto H; Nakagawa M; Sakamoto N; Tobe Y; Furuya T; Tomita M; Hayashi M
Int J Pharm; 2013 Sep; 453(2):363-70. PubMed ID: 23742974
[TBL] [Abstract][Full Text] [Related]
36. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
37. Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model.
Fasano A; Uzzau S
J Clin Invest; 1997 Mar; 99(6):1158-64. PubMed ID: 9077522
[TBL] [Abstract][Full Text] [Related]
38. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.
Föger F; Kopf A; Loretz B; Albrecht K; Bernkop-Schnürch A
Amino Acids; 2008 Jun; 35(1):233-41. PubMed ID: 17726639
[TBL] [Abstract][Full Text] [Related]
39. Investigation of coco-glucoside as a novel intestinal permeation enhancer in rat models.
Aguirre TA; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):856-65. PubMed ID: 25445305
[TBL] [Abstract][Full Text] [Related]
40. An Assessment of the Permeation Enhancer, 1-phenyl-piperazine (PPZ), on Paracellular Flux Across Rat Intestinal Mucosae in Ussing Chambers.
Bzik VA; Brayden DJ
Pharm Res; 2016 Oct; 33(10):2506-16. PubMed ID: 27387171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
